Zobrazeno 1 - 10
of 591
pro vyhledávání: ''
Autor:
Charles Vidal, Dorothée Valance, Jérôme Allyn, Nicolas Allou, Léandre Girard, Amélie Renou, Gilbert Dubois, Marjolaine Davineau, Berenice Puech, Céline Gonzalez, Eric Braunberger, Fares Djemili
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:2376-2384
Current guidelines consider obesity to be a relative contraindication to venoarterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock. The authors investigated the effect of body mass index (BMI) on clinical outcomes in
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:2313-2321
Objective The objective of the present study was to evaluate morphine consumption and pain scores 24 hours postoperatively to compare the effects of a bilateral pectointercostal fascial block (PIFB) with those of a transversus thoracic muscle plane b
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:1715-1719
Heparin-induced thrombocytopenia (HIT) is a serious complication in patients exposed to heparin, leading to thrombocytopenia and, potentially, thrombosis. This disorder is challenging in cardiac surgery when anticoagulation for cardiopulmonary bypass
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36(3):840-846
Objectives Perioperative hyperglycemia is associated with poor postoperative recovery, including compromised immune function and increased risk of infection. A closed-loop glycemic control system (artificial pancreas) has demonstrated strict safe per
Autor:
Olivier Brugière, Marc Fischler, Benjamin Zuber, Alexandre Vallée, A. Roux, Matthieu Glorion, Charles Cerf, Marc Vasse, Avit Guirimand, François Parquin, Tiffany Pascreau, Morgan Le Guen, Edouard Sage, Julien Fessler, Carole Ichai
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:794-804
Objective Many prognostic factors of grade-3 primary graft dysfunction at post-operative day 3 (PGD3-T72) have been reported but intraoperative blood lactate level has not been studied. The present retrospective study was done to test the hypothesis
Autor:
Adrien Bouglé, Ahmed Charfeddine, Basile Kerleroux, Ludovic Michaud, Pauline Dureau, Jean-Michel Constantin, Pascal Leprince, Mary Regan
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:825-832
Objectives The authors aimed to identify risk factors associated with prolonged mechanical ventilation (PMV) after scheduled cardiac surgery under cardiopulmonary bypass (CPB). Design A single-center, observational study. Setting Tertiary hospital. P
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:684-689
Objectives Recombinant activated factor VIIa (rVIIa) is used off-label for refractory bleeding after cardiac surgery. This study reviewed the indications, usage rates, and complications of rVIIa. Design A retrospective case-control observational stud
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:855-861
Objectives Blood-processing techniques and preservation conditions cause storage lesions, possibly leading to adverse outcomes after transfusion. The authors investigated the metabolic changes and deformability of red blood cells (RBCs) during storag
Autor:
Maria Grazia Calabrò, Alberto Zangrillo, Marina Pieri, Francesco Vettorello, Anna Mara Scandroglio
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:529-533
Objective Current evidence supports centralization of patients with refractory acute respiratory distress syndrome (ARDS) to institutions with a high level of expertise and with extracorporeal membrane oxygenation (ECMO) capabilities. The aim of this
Autor:
Rajat Kapoor, Chadi A. Hage, Shelley Porter, Mckenna Jennings, Eve Anderson, Salwa Moiz, Russell Trigonis, Nikki Smith, Jose Garcia, Omar Rahman
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia
Objectives : The COVID-19 pandemic has been associated with cases of refractory acute respiratory distress syndrome (ARDS) sometimes requiring support with extracorporeal membrane oxygenation (ECMO). Bivalirudin can be used for anticoagulation in pat